Evidence map›Paper›PMID 32869399›Full record

Trial reportPediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology2021

A randomized trial of oral immunotherapy for pediatric cow's milk-induced anaphylaxis: Heated vs unheated milk.

Ken-Ichi Nagakura, Sakura Sato, Yoko Miura, Makoto Nishino, Kyohei Takahashi, Tomoyuki Asaumi, Kiyotake Ogura, Motohiro Ebisawa, Noriyuki Yanagida

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. A randomized trial of oral immunotherapy for pediatric cow's milk-induced anaphylaxis: Heated vs unheated milk.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2021
    Trial
  4. Article
  5. Recent Advances in Oral Immunotherapy for Food Allergies.Clinical reviews in allergy & immunology · 2025
    Review
  6. Effects of Food Processing on Allergenicity.Current allergy and asthma reports · 2025
    Review
  7. Recent advances in food allergen immunotherapy.Clinical and experimental pediatrics · 2024
    Article
  8. Review
  9. Practical issues of oral immunotherapy for egg or milk allergy.Clinical and experimental pediatrics · 2024
    Article
  10. Review
  11. Review
  12. Oral Immunotherapy in Food Allergy: Where Are We Now?Allergy, asthma & immunology research · 2023
    Review
  13. Article
  14. Review
  15. Comments on nitric oxide in children with asthma, low-dose oral immunotherapy for cow's milk allergy, and SARS-Cov-2 testing in school children.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2021
    Article
  16. Biomarkers in oral immunotherapy.Journal of Zhejiang University. Science. B
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ken-Ichi NagakuraDepartment of Pediatrics, National Hospital Organization Sagamihara National Hospital, Kanagawa, Japan.ORCID 0000-0002-9381-9044
Sakura SatoDepartment of Allergy, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Kanagawa, Japan.ORCID 0000-0003-3674-0759
Yoko MiuraDepartment of Pediatrics, National Hospital Organization Sagamihara National Hospital, Kanagawa, Japan.ORCID 0000-0001-8887-6901
Makoto NishinoDepartment of Pediatrics, National Hospital Organization Sagamihara National Hospital, Kanagawa, Japan.ORCID 0000-0002-5381-8848
Kyohei TakahashiDepartment of Pediatrics, National Hospital Organization Sagamihara National Hospital, Kanagawa, Japan.ORCID 0000-0003-1220-7386
Tomoyuki AsaumiDepartment of Pediatrics, National Hospital Organization Sagamihara National Hospital, Kanagawa, Japan.ORCID 0000-0002-7464-5421
Kiyotake OguraDepartment of Pediatrics, National Hospital Organization Sagamihara National Hospital, Kanagawa, Japan.
Motohiro EbisawaDepartment of Pediatrics, Jikei University School of Medicine, Tokyo, Japan.ORCID 0000-0003-4117-558X
Noriyuki YanagidaDepartment of Pediatrics, National Hospital Organization Sagamihara National Hospital, Kanagawa, Japan.ORCID 0000-0001-9643-744X
Juntendo University · JPNational Sagamihara Hospital · JPJikei University School of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSevere reactions may develop during cow's milk (CM) oral immunotherapy (OIT). We investigated the safety and efficacy of low-dose OIT with heated milk (HM) or unheated milk (UM) in children with anaphylaxis.

methodsChildren with symptom onset after ingestion of 3-mL HM on a double-blind, placebo-controlled food challenge were randomly assigned to the HM (n = 17) or UM (n = 16) group. HM group ingested milk powder heated at 125°C for 30 seconds, whereas the UM group used UM. Patients were hospitalized for 5 days; the HM or UM was gradually increased to 3 mL/day; 3-mL/day ingestion was continued at home. One year later, the patients underwent 2-day consecutive 3- and 25-mL HM-oral food challenges (OFCs) after 2-week avoidance.

resultsAt baseline, milk- and casein-specific immunoglobulin E (IgE) levels were 56.0 and 51.4 kUA/L in the HM group, and 55.2 and 65.6 kUA/L in the UM group, respectively. One year later, 35% and 18% in the HM group and 50% and 31% in UM group passed the 3 and 25 mL OFCs, respectively. Rates of moderate or severe symptoms and respiratory symptoms per home dose were significantly lower in the HM than in the UM group (0.7% and 1.2% vs 1.4% and 2.6%, respectively, P < .001). β-lactoglobulin-specific IgG

conclusionsHM-OIT induced immunological changes more safely than the UM-OIT. The possibility of lower treatment efficacy with HM-OIT needs to be evaluated in larger studies.

Indexed as

AnaphylaxisMilk HypersensitivityAdministration, OralAnimalsCattleDesensitization, ImmunologicFemaleHumansMilkanaphylaxiscaseincow's milk allergydesensitizationheatedmilkoral immunotherapyrandomized controlled trialunheatedβ-lactoglobulin

Identifiers

PMID32869399
PMCPMC7821001
OpenAlexW3081994238

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.